SEC Form 4 · accession 0001761913-18-000001
GENEREX BIOTECHNOLOGY CORP · GNBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold Gray Haines
Other
Period of report
Dec 4, 2018
Accepted (ET)
Dec 14, 2018 · 12:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001059784
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2018 | P | 300 | $1.03 | A | 300 | D | |
| Common Stock | Dec 7, 2018 | P | 8,000 | $1.05 | A | 8,000 | D |
Table II — derivative securities
No Table II lines on this filing.